Legal Representation
Attorney
mathew auric
USPTO Deadlines
Next Renewal Deadline
1399 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-05-07)
Due Date
May 07, 2029
Grace Period Ends
November 07, 2029
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| May 7, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Jul 28, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| May 7, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Feb 19, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Feb 19, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 30, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 14, 2019 | ALIE | A | ASSIGNED TO LIE |
| Dec 20, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 18, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 18, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 18, 2018 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Dec 18, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Dec 13, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Dec 13, 2018 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Dec 13, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 11, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 11, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 11, 2018 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Dec 11, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Dec 7, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 31, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Aug 25, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Nutraceuticals for use as a dietary supplement containing pregnenlone
First Use Anywhere:
Jan 14, 2000
First Use in Commerce:
Jan 14, 2000
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PREGNENOLONE"